Literature DB >> 1179724

Guanidine hydrochloride therapy in neuromuscular disorders.

W C Wiederholt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1179724      PMCID： PMC1129838     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  4 in total

1.  The effect of guanidine on neuromuscular transmission.

Authors:  M OTSUKA; M ENDO
Journal:  J Pharmacol Exp Ther       Date:  1960-03       Impact factor: 4.030

2.  Detailed analysis of neuromuscular transmission in a patient with the myasthenic syndrome sometimes associated with bronchogenic carcinoma.

Authors:  D Elmqvist; E H Lambert
Journal:  Mayo Clin Proc       Date:  1968-10       Impact factor: 7.616

3.  The administration of guanidine in amyotrophic lateral sclerosis.

Authors:  F H Norris; P R Calanchini; R J Fallat; S Panchari; B Jewett
Journal:  Neurology       Date:  1974-08       Impact factor: 9.910

4.  Botulism and guanidine.

Authors:  M Cherington; D W Ryan
Journal:  N Engl J Med       Date:  1968-04-25       Impact factor: 91.245
  4 in total
  1 in total

1.  Effects of guanidine on synaptic transmission in the spinal cord of the frog.

Authors:  P Grafe; U Sonnhof
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-12       Impact factor: 3.000
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.